Preclinical and cosmetic research on hair-follicle signaling , anagen/follicle-support markers, and scalpskin parameters
For those seeking more dramatic results, Roche is developing CT388, a GLP-1/GIP receptor that saw around half of participants lose at least 20% of their body weight in early trials
Uncovering the impact of alcohol on internal organs and reproductive health: exploring TLR4/NF-kB and CYP2E1/ROS/Nrf2 pathways
Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells
Recently, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide and tirzepatide, have emerged as effective pharmacologic agents for sustained weight loss and are under investigation in oncology
However, "safe" does not mean "one size fits all." Everyones internal chemistry is different